🇺🇸 FDA
Patent

US 7947737

Method of treating hypertension and reducing serum lipase activity

granted A61KA61K31/20

Quick answer

US patent 7947737 (Method of treating hypertension and reducing serum lipase activity) held by Aker Biomarine AS expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aker Biomarine AS
Grant date
Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/20